Quantitative multiplex immune fluorescence to reveal the impact of chemoradiation therapy on modulation of the immune micro-environment of pancreatic ductal adenocarcinoma.

4122Background: Patients with advanced pancreatic ductal adenocarcinoma (PDA) continue to have median survival under one year and to date immunotherapy has largely been unsuccessful. Radiation or c...